Location History:
- Saffron Walden, GB (2015)
- Essex, GB (2016 - 2017)
Company Filing History:
Years Active: 2015-2017
Title: Adeline Morel: Innovator in Pharmaceutical Chemistry
Introduction
Adeline Morel is a prominent inventor based in Essex, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of TYK2 inhibitors. With a total of three patents to her name, Morel's work has the potential to impact the treatment of various immunological and inflammatory disorders.
Latest Patents
Among her latest patents, Morel has developed heterocyclyl pyrimidine analogues as TYK2 inhibitors. These compounds are described by a specific formula, wherein the variables R, R, and X have defined meanings as cited in the detailed description and claims. The compounds are particularly useful for the treatment or prophylaxis of immunological, inflammatory, autoimmune, and allergic disorders, as well as immunologically-mediated diseases. Additionally, the invention encompasses pharmaceutical compositions that include these compounds and their application as medicaments.
Career Highlights
Throughout her career, Adeline Morel has worked with notable companies such as Cellzome Limited and Cellzone Limited. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical development and innovation.
Collaborations
Morel has collaborated with several professionals in her field, including Laura Convery and Mihiro Sunose. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Adeline Morel's innovative work in the development of TYK2 inhibitors showcases her dedication to improving treatments for various medical conditions. Her contributions to pharmaceutical chemistry are noteworthy and continue to influence the industry.